List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 337 studies with search of: "Gliosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Temozolomide;   Radiation: Radiation;   Drug: Sorafenib
2 Recruiting Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Avastin;   Drug: Tarceva;   Drug: Temodar
3 Recruiting Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas
Conditions: Glioblastoma;   Gliosarcoma;   Brain Tumor
Intervention: Drug: Avastin, radiation, temozolomide, and irinotecan
4 Active, not recruiting Avastin in Combo w Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Avastin, & temozolomide
5 Active, not recruiting Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Gliosarcoma
Interventions: Drug: enzastaurin;   Drug: temozolomide;   Radiation: radiation
6 Active, not recruiting Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
Conditions: Glioblastoma Multiforme;   Gliosarcoma
Interventions: Drug: Tarceva;   Drug: Temodar;   Procedure: Radiation Therapy
7 Recruiting Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: High Grade Glioma;   Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
8 Terminated Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temozolomide
9 Recruiting Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma
Intervention: Drug: Vandetanib and Etoposide
10 Recruiting Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Avastin and Bortezomib
11 Active, not recruiting Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Imatinib Mesylate & Hydroxyurea
12 Active, not recruiting Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar, Etoposide & Irinotecan
13 Recruiting Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Etoposide
14 Active, not recruiting Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Gleevec, RAD001, and Hydroxyurea
15 Active, not recruiting Ph II Imatinib Mesylate + Hydroxyurea in Treatment for Pts w Recurrent/Progressive Meningioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Imatinib Mesylate and Hydroxyurea
16 Recruiting A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
Interventions: Other: Taking EIAEDs (enzyme-inducing anticonvulsant medications);   Other: NOT taking EIAEDs
17 Active, not recruiting Sarasar and Temodar for Glioblastoma Multiforme Patients
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Brain Tumors
Interventions: Drug: Sarasar;   Drug: Temodar
18 Active, not recruiting PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma;   Anaplastic Astrocytoma
Intervention: Drug: Temodar and SCH 66336
19 Recruiting Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Zactima, Gleevec, Hydroxyurea
20 Withdrawn Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Glioma
Interventions: Other: enzyme-inducing anti-epileptic drugs;   Other: enzyme-inducing anti-epileptic drugs

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services